Home › Companies › IDEAYA Biosciences, Inc. › 2025-2026

IDEAYA Biosciences, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and IDEAYA Biosciences, Inc.’s Form 8-K, filed 2026-06-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.

6Reported items
288Asset managers
1,536Fund votes
2026-06-16Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IDEAYA Biosciences, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by IDEAYA Biosciences, Inc.

These tallies are IDEAYA Biosciences, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IDEAYA Biosciences, Inc. — official shareholder meeting results, meeting held 2026-06-16
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Yujiro S. Hata	70,546,418	--	--	2,470,077	10,089,343	Majority: yes
Elect Director: M. Garret Hampton, Ph.D.	56,718,637	--	--	16,297,858	10,089,343	Majority: yes
Elect Director: Catherine J. Mackey, Ph.D.	70,281,521	--	--	2,734,974	10,089,343	Majority: yes

Source: IDEAYA Biosciences, Inc., Form 8-K, filed with the SEC on 2026-06-23 — read the filing on EDGAR.

How asset managers voted at the IDEAYA Biosciences, Inc. 2025-2026 meeting

Each item below shows how the 288 asset managers that disclosed a IDEAYA Biosciences, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IDEAYA Biosciences, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and

SECTION 14A SAY-ON-PAY VOTES

Combines 9 wordings of this item as funds reported it.

87% fund support · no official result

FOR 87%13%

The 279 asset managers below cast 87% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 87.0%AGAINST: 13.0%ABSTAIN: 0.0%NOT VOTED: 0.0%

Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA Biosciences, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	22,459,862	0	0	For
Janus Henderson	13,520,075	0	0	For
BlackRock	6,884,731	37,992	0	For
Capital Group	0	5,163,543	0	Against
Capital Research Global Investors	0	5,163,543	0	Against
Vanguard	5,141,530	9	1	For
Logos Global Management LP	3,299,287	0	0	For
State Street	2,935,994	17,194	0	For
Federated Hermes	2,863,260	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,281,996	0	0	For
T. Rowe Price	2,254,079	0	0	For
JANUS INVESTMENT FUND	2,156,609	0	0	For
DEERFIELD MANAGEMENT COMPANY, L.P.	1,684,401	0	0	For
Charles Schwab	1,437,907	0	0	For
Fiera Capital Corp	1,300,996	78,024	0	For
BNP Paribas Asset Management Holding S.A.	1,231,368	0	0	For
Candriam S.C.A.	0	998,708	0	Against
Ensign Peak Advisors, Inc	899,504	0	0	For
Nuveen	713,678	0	0	For
TIAA	701,310	0	0	For
PICTET ASSET MANAGEMENT SA	641,134	0	0	For
Victory Capital	632,082	0	0	For
Aberdeen	618,436	0	0	For
Goldman Sachs	605,568	0	0	For
Dimensional	595,093	0	0	For

Showing the 25 largest of 279 asset managers. See all 279 in the interactive database.

2. To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 70,281,521WITHHELD: 2,734,974

IDEAYA Biosciences, Inc.’s own tally for this item (“Elect Director: Catherine J. Mackey, Ph.D.”): 70,281,521 for, 2,734,974 withheld, per its Form 8-K filed 2026-06-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,856,154 outstanding shares: 80% for, 3% withheld (83% of the company cast a for/withheld vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (32,881,085 for, 0 against).

FOR 98%

FOR: 32,881,085 (98.4%)ABSTAIN: 544,531 (1.6%)

Largest asset managers voting on “To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their s” at IDEAYA Biosciences, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Fidelity	9,288,041	0	For
Capital Group	5,163,543	0	For
Vanguard	4,453,982	9	For
BlackRock	3,230,366	0	For
JANUS INVESTMENT FUND	2,156,609	0	For
State Street	1,648,817	0	For
Federated Hermes	1,431,630	0	For
T. Rowe Price	904,596	0	For
Charles Schwab	718,071	0	For
TIAA	701,310	0	For
Dimensional	0	447,090	Abstain
GENERAL AMERICAN INVESTORS CO INC	301,057	0	For
Victory Capital	300,956	0	For
First Trust	275,294	0	For
Goldman Sachs	248,318	0	For
American Century	242,229	0	For
Equitable	127,433	68,180	For
QUANTITATIVE MASTER SERIES LLC	137,423	0	For
New York Life	133,863	0	For
Jackson National	112,404	16,326	For
Tema ETF Trust	128,546	0	For
JPMorgan	119,428	0	For
FRANKLIN STRATEGIC SERIES	81,852	0	For
ALPS ETF Trust	70,780	0	For
Russell Investments	61,680	0	For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

3. To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD 22%

FOR: 56,718,637WITHHELD: 16,297,858

IDEAYA Biosciences, Inc.’s own tally for this item (“Elect Director: M. Garret Hampton, Ph.D.”): 56,718,637 for, 16,297,858 withheld, per its Form 8-K filed 2026-06-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,856,154 outstanding shares: 65% for, 19% withheld (83% of the company cast a for/withheld vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (31,284,057 for, 0 against).

FOR 94%

FOR: 31,284,057 (93.6%)ABSTAIN: 2,141,559 (6.4%)

Largest asset managers voting on “To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their s” at IDEAYA Biosciences, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Fidelity	9,288,041	0	For
Capital Group	5,163,543	0	For
Vanguard	4,449,943	4,049	For
BlackRock	3,230,366	0	For
JANUS INVESTMENT FUND	2,076,415	80,194	For
State Street	1,646,922	1,895	For
Federated Hermes	1,431,630	0	For
T. Rowe Price	904,596	0	For
Charles Schwab	718,071	0	For
TIAA	701,310	0	For
Dimensional	0	447,090	Abstain
GENERAL AMERICAN INVESTORS CO INC	301,057	0	For
Victory Capital	0	300,956	Abstain
First Trust	0	275,294	Abstain
Goldman Sachs	248,318	0	For
American Century	0	242,229	Abstain
Equitable	127,433	68,180	For
QUANTITATIVE MASTER SERIES LLC	137,423	0	For
New York Life	133,863	0	For
Jackson National	112,404	16,326	For
Tema ETF Trust	128,546	0	For
JPMorgan	119,428	0	For
FRANKLIN STRATEGIC SERIES	0	81,852	Abstain
ALPS ETF Trust	0	70,780	Abstain
Russell Investments	0	61,680	Abstain

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

4. To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 70,546,418WITHHELD: 2,470,077

IDEAYA Biosciences, Inc.’s own tally for this item (“Elect Director: Yujiro S. Hata”): 70,546,418 for, 2,470,077 withheld, per its Form 8-K filed 2026-06-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,856,154 outstanding shares: 80% for, 3% withheld (83% of the company cast a for/withheld vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (32,881,087 for, 0 against).

FOR 98%

FOR: 32,881,087 (98.4%)ABSTAIN: 544,529 (1.6%)

Largest asset managers voting on “To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their s” at IDEAYA Biosciences, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Fidelity	9,288,041	0	For
Capital Group	5,163,543	0	For
Vanguard	4,453,984	7	For
BlackRock	3,230,366	0	For
JANUS INVESTMENT FUND	2,156,609	0	For
State Street	1,648,817	0	For
Federated Hermes	1,431,630	0	For
T. Rowe Price	904,596	0	For
Charles Schwab	718,071	0	For
TIAA	701,310	0	For
Dimensional	0	447,090	Abstain
GENERAL AMERICAN INVESTORS CO INC	301,057	0	For
Victory Capital	300,956	0	For
First Trust	275,294	0	For
Goldman Sachs	248,318	0	For
American Century	242,229	0	For
Equitable	127,433	68,180	For
QUANTITATIVE MASTER SERIES LLC	137,423	0	For
New York Life	133,863	0	For
Jackson National	112,404	16,326	For
Tema ETF Trust	128,546	0	For
JPMorgan	119,428	0	For
FRANKLIN STRATEGIC SERIES	81,852	0	For
ALPS ETF Trust	70,780	0	For
Russell Investments	61,680	0	For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

5. To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026;

AUDIT-RELATED

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 73 asset managers below cast 99.9% of the shares they voted on this item FOR (33,430,783 for, 632 against).

FOR: 33,430,783 (100.0%)AGAINST: 632 (0.0%)ABSTAIN: 1 (0.0%)

Largest asset managers voting on “To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers” at IDEAYA Biosciences, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	9,288,041	0	0	For
Capital Group	5,163,543	0	0	For
Vanguard	4,453,990	0	1	For
BlackRock	3,230,366	0	0	For
JANUS INVESTMENT FUND	2,156,609	0	0	For
State Street	1,648,752	65	0	For
Federated Hermes	1,431,630	0	0	For
T. Rowe Price	904,596	0	0	For
Charles Schwab	718,071	0	0	For
TIAA	701,310	0	0	For
Dimensional	447,090	0	0	For
GENERAL AMERICAN INVESTORS CO INC	301,057	0	0	For
Victory Capital	300,956	0	0	For
First Trust	275,294	0	0	For
Goldman Sachs	248,318	0	0	For
American Century	242,229	0	0	For
Equitable	195,613	0	0	For
QUANTITATIVE MASTER SERIES LLC	137,423	0	0	For
New York Life	133,863	0	0	For
Jackson National	128,730	0	0	For
Tema ETF Trust	128,546	0	0	For
JPMorgan	119,428	0	0	For
FRANKLIN STRATEGIC SERIES	81,852	0	0	For
ALPS ETF Trust	70,780	0	0	For
Russell Investments	61,680	0	0	For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (867 for, 0 against).

FOR: 867 (100.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at IDEAYA Biosciences, Inc., 2025-2026
Asset manager	For	Vote
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	833	For
Coyle Financial Counsel LLC	34	For
BIT Capital GmbH	0	--
Torrey Growth & Income Advisors	0	--

Largest IDEAYA Biosciences, Inc. shareholders voting in 2025-2026

Ranked by the number of IDEAYA Biosciences, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 87,856,154 shares outstanding at the time of that meeting.

Top IDEAYA Biosciences, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	25.56%
2	Janus Henderson	15.39%
3	BlackRock	7.88%
4	Capital Group	5.88%
5	Capital Research Global Investors	5.88%
6	Vanguard	5.85%
7	Logos Global Management LP	3.76%
8	State Street	3.36%
9	Federated Hermes	3.26%
10	GEODE CAPITAL MANAGEMENT, LLC	2.60%

Reported IDEAYA Biosciences, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

IDEAYA Biosciences, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
FMR (Fidelity)	14.99%	13F
FMR LLC	14.38%	DEF14A
BlackRock	9.61%	13F
JANUS HENDERSON GROUP PLC	8.27%	13G
Capital Research Global Investors	6.01%	13G
Vanguard Group	5.71%	13F
State Street	4.30%	13F
Federated Hermes, Inc.	3.87%	13G
Goldman Sachs	2.18%	13F
Point72 Asset Management, L.P.	2.10%	13G

Percentages above are of 87,856,154 shares outstanding, as reported by IDEAYA Biosciences, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IDEAYA Biosciences, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At IDEAYA Biosciences, Inc.'s shareholder meeting held 2026-06-16, in the 2025-2026 proxy season, 288 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,536 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IDEAYA Biosciences, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — the reporting funds cast 87% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

IDEAYA Biosciences, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).